Table 3.
Author (Year) | Study Design | N. Cases | Clinical Appearance | Pathological Diagnosis | Oral Sites | OCT Patterns Parameters/Evaluation |
|
---|---|---|---|---|---|---|---|
1 | Ridgway (2006) [41] | Case series | 41 | Not specified benign and malignant lesions | Begnin lesions, OL, CIS, OSCC | Buccal mucosa, Floor of mouth, Gingiva, Hard palate, Lip, Tongue | SS, BM/LP |
2 | Wilder-Smith (2009) [40] | Preliminary Study | 50 | Leukoplakia, erythroplakia | Dysplasia (mild, moderate, severe) CIS, OSCC | Tongue, Buccal mucosa, Floor of mouth | SEL, BM, LP |
3 | Volgger (2012) [42] | Prospective diagnostic trial | 100 | Leukoplakia, erythroplakia | OSCC, dysplasia, OLP | Buccal mucosa, Floor of mouth, Gingiva, Palate, Lip, Tongue (detailed only for healthy mucosa) |
KL, EP, ET, BM, LP |
4 | Gambino (2020) [38] | Case control study | 20 | Atrophic-erosive OLP | OLP | Buccal mucosa | EP, BM, LP |
5 | Panzarella (2021) [43] | Observational study | 43 | DG | OLP, PV, MMP | Gingiva | SEL, BM, LP |
6 | Panzarella (2022) [19] | Descriptive pilot Study | 30 | Suspected OSCC | OSCC | Tongue, Gingiva, Buccal mucosa | KL, SEL, BM, LP |
7 | Gambino 2022 [45] | Case/control study | 50 | Non-healing Ulcerations | Traumatic lesions, OSCC | Buccal mucosa, Gingiva, Tongue | EP, BM, LP |
8 | Gambino (2023) [39] | Case series | 11 | White, red-white lesions, ulcers | PVL, OLP, OL, GVHD, K-MICRO | Tongue, Gingiva, Buccal mucosa | KL, EP, BM, LP |
9 | Gruda (2023) [44] | Case series | 15 | OLP, leukoplakia | OLP, OL, OSCC | Buccal mucosa, Tongue | EP, EP Re, LP Re, BM |